EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS092-18920 
Organism
Homo sapiens 
Tissue/cell
HFF 
Coordinate
chr16:2046650-2047650 
Target genes
Number: 46             
NameEnsembl ID
C16orf42ENSG00000007520
GNPTGENSG00000090581
LA16cENSG00000260954
IFT140ENSG00000187535
CRAMP1LENSG00000007545
HN1LENSG00000206053
MAPK8IP3ENSG00000138834
NME3ENSG00000103024
MRPS34ENSG00000074071
EME2ENSG00000197774
SPSB3ENSG00000162032
NUBP2ENSG00000095906
FAHD1ENSG00000180185
HAGHENSG00000063854
MSRB1ENSG00000198736
NDUFB10ENSG00000140990
AC005363.9ENSG00000255513
RPS2ENSG00000140988
SNHG9ENSG00000255198
TBL3ENSG00000183751
NOXO1ENSG00000196408
GFERENSG00000127554
SYNGR3ENSG00000127561
AC005606.14ENSG00000261790
AC005606.15ENSG00000260107
ZNF598ENSG00000167962
NPWENSG00000183971
SLC9A3R2ENSG00000065054
TSC2ENSG00000103197
NTHL1ENSG00000065057
PKD1ENSG00000008710
RAB26ENSG00000167964
RP11ENSG00000260260
TRAF7ENSG00000131653
MLST8ENSG00000167965
C16orf79ENSG00000182685
PGPENSG00000184207
E4F1ENSG00000167967
DNASE1L2ENSG00000167968
ECI1ENSG00000167969
AC009065.1ENSG00000167970
RNPS1ENSG00000205937
ABCA3ENSG00000167972
CCNFENSG00000162063
ATP6V0CENSG00000185883
PDPK1ENSG00000140992
Number of super-enhancer constituents: 13             
IDCoordinateTissue/cell
SE_68103chr16:2008747-2090503TC32
SE_68104chr16:2008747-2090503TC32
SE_68105chr16:2008747-2090503TC32
SE_68106chr16:2008747-2090503TC32
SE_68107chr16:2008747-2090503TC32
SE_68108chr16:2008747-2090503TC32
SE_68109chr16:2008747-2090503TC32
SE_68110chr16:2008747-2090503TC32
SE_68111chr16:2008747-2090503TC32
SE_68112chr16:2008747-2090503TC32
SE_68113chr16:2008747-2090503TC32
SE_68114chr16:2008747-2090503TC32
SE_68115chr16:2008747-2090503TC32
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr1620469212047227
Number: 1             
IDChromosomeStartEnd
GH16I001997chr1620471002049246
Enhancer Sequence
TACTCGGGAG GCTGAGACAG AATCGCTTGA ACCCGGGAGG CGGACGTTGT GGTGAGCCGA 60
GATCACGCTT TCGCACTCCA GCCCGGGCAA GAAGAGCGAA TCTCCCTCTC AAAACAAAAG 120
TCATTTTTAG CCGAACACAG TGGCTCATTC CTGTAACCTG GCACTTTGAG AGGCCGAGGC 180
AGGAGGATTG TTGGAGCCCA GGAGGTCAAG GCGAGCCTTG GCAACATAGC AAGACCCCTT 240
CTCTACAAAA AATATCAGCT GGGCATGGTG GCGCACACTT GTAGTTCCAA CTACTCAGGA 300
GGCTGAGGTG GGTCACCTGA GCCTCAGGAG GTCAAGACTG CACTGAGCTG AGATCACACC 360
ACTGCACTCC AGCCTGGGTG ACAGGGCCAG ACCCGGAAAG AGAAGTTCTT TCCAATAACC 420
TTAAGGAAAC AGCCCATTTC TCAGACTGCT CTACTCTTCT GTGGAGCTGG TCTTGCTTAG 480
GAACCTACCA TCCCCTGCCA AGTGGGCATC AGCTGTGAGG CGCCTCTGGT GTGGGGGGAA 540
TGCAGGTGGC CCCTACCCAG CCTCTCATCT CCTAGCCAGC CCCAGCATGG CCATCACCCA 600
GGGGACACAG TTGAGTCCCA GTGTCCAAGT CCTCAGCTAC AGGGGGGCAG TGCCAATGCC 660
GCCACATGGC TGACCCAGCC CCTCTGCAGC CACTGACCTT GGCTCTTCAT CACCATGGGA 720
GCCCCTTTCT GCTTGCTTTA GAGAAATTTC CCCACTTTCT CTGATCTGAG GACATATTCT 780
TGGCCTTATT TGAATGTGGC TGTGTTTAGA GCATTTTTCC TACTTCTATG TGCTGGAAGC 840
AGAAAGTGAT TACCGTATGT GTCTGGTCTC CCTCCAAAAA CACCAGATCC AGATAATTAC 900
GCTCAAATTA TTTCGCTGCA GTATTTCAGA TGTCCCCTCC ACCCTGTTTC TAAATTTGGC 960
TTCAGGGTAT ACTCAGAAGA CAGAGAAGCT CAGAACACCA 1000